Asian markets look to continue upward run on vaccine hopes
By Pete Schroeder (Reuters) - Asian shares look set to continue a march upwards as optimism over a coronavirus vaccine carry weight over the ongoing spread of the disease and simmering U.S.-China tensions. Australian S&P/ASX 200 futures rose 0.37% in early trading
By Pete Schroeder
(Reuters) - Asian shares look set to continue a march upwards as optimism over a coronavirus vaccine carry weight over the ongoing spread of the disease and simmering U.S.-China tensions.
Australian S&P/ASX 200 futures
E-mini futures for the S&P 500
MSCI's gauge of stocks across the globe <.MIWD00000PUS> closed up 1.16%.
A run of promising news in efforts to develop a COVID-19 vaccine ran through U.S. markets. An experimental vaccine produced by biotech startup Moderna Inc
"U.S. equities continued to defy all gravity as investor optimism revels amid the progress in developing a vaccine which continues to reign supreme," wrote Stephen Innes, chief global markets strategist at AxiCorp, in an analyst note.
In the United States, stocks closed sharply higher on the vaccine news, buttressed by a strong quarterly report from Goldman Sachs
A new report from the Federal Reserve also found U.S. businesses saw an uptick in activity as states relaxed restrictions, although uncertainty about the outlook remained with coronavirus cases spreading.
The Dow Jones Industrial Average <.DJI> rose 0.85%, while the S&P 500 <.SPX> gained 0.91% and the Nasdaq Composite <.IXIC> grew 0.59%.
Oil prices rose thanks to a drop in U.S. crude inventories, but gains were limited by plans from OPEC and its allies to ease supply curbs. Brent crude
Investors appeared willing to take on more risk in currency markets, pushing the safe-haven U.S. dollar to a one-month low. The dollar index <=USD> fell 0.105%, dropping below 96 for the first time since June.
The risk appetite was also evident as U.S. Treasury yields rose and the yield curve steepened, indicating a wider spread between long- and short-term interest rates.
Investors will be watching for new economic data out of China, which will release figures on second-quarter GDP data on Thursday, along with June factory output, retail sales and fixed-asset investment. A Reuters poll found analysts expect China to report 2.5% economic growth, reversing a 6.8% first-quarter decline driven by the pandemic.
(Reporting by Pete Schroeder in Washington; Editing by Tom Brown)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Doina Chiacu and Valerie Volcovici WASHINGTON (Reuters) - Top aides to President Donald Trump on Sunday raised the possibility of the Congress passing piecemeal coronavirus relief legislation - an approach opposed by Democrats - with a deadline looming on the expiration of enhanced unemployment benefits. A day before Senate Republicans were due to introduce a $1 trillion coronavirus relief bill that includes reduced federal unemployment benefits, U.S.
By Yury Zolotarev and Andrew Osborn KHABAROVSK/MOSCOW (Reuters) - Tens of thousands marched in the Russian far east on Saturday, the third such weekend protest in a row, to express their anger over what they say is President Vladimir Putin's mishandling of a local political crisis. Residents of Khabarovsk, around 3,800 miles (6,110 km) and seven time zones east of Moscow, are unhappy about the detention this month of the wider region's popular governor, Sergei Furgal, who was arrested on murder charges he denies.
LONDON (Reuters) - Britain's government is set to announce all travellers from Spain arriving after midnight (2300 GMT) on Saturday will need to spend two weeks in quarantine in case they are infected with coronavirus, the Sunday Times newspaper reported. "Second wave of Covid-19 there has prompted decision to kick Spain off the safe country list," the newspaper's political editor, Tim Shipman, said on Twitter. Britain's health ministry had no immediate comment on the report.